Temmune Therapeutics

Temmune Tx is developing a best-in-class Kv1.3 inhibitor that targets pathogenic effector memory T cells to block chronic inflammation without broad immunosuppression, offering a safer and more convenient alternative to injectable biologics to treat autoimmune diseases such as atopic dermatitis.